ID   SENP2_RAT               Reviewed;         588 AA.
AC   Q9EQE1;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   02-DEC-2020, entry version 134.
DE   RecName: Full=Sentrin-specific protease 2;
DE            EC=3.4.22.-;
DE   AltName: Full=Axin-associating molecule;
DE            Short=Axam;
DE   AltName: Full=Sentrin/SUMO-specific protease SENP2;
GN   Name=Senp2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=10944533; DOI=10.1074/jbc.m005984200;
RA   Kadoya T., Kishida S., Fukui A., Hinoi T., Michiue T., Asashima M.,
RA   Kikuchi A.;
RT   "Inhibition of Wnt signaling pathway by a novel Axin-binding protein.";
RL   J. Biol. Chem. 275:37030-37037(2000).
RN   [2]
RP   FUNCTION, AND MUTAGENESIS OF CYS-547.
RX   PubMed=11997515; DOI=10.1128/mcb.22.11.3803-3819.2002;
RA   Kadoya T., Yamamoto H., Suzuki T., Yukita A., Fukui A., Michiue T.,
RA   Asahara T., Tanaka K., Asashima M., Kikuchi A.;
RT   "Desumoylation activity of Axam, a novel Axin-binding protein, is involved
RT   in downregulation of beta-catenin.";
RL   Mol. Cell. Biol. 22:3803-3819(2002).
CC   -!- FUNCTION: Protease that catalyzes two essential functions in the SUMO
CC       pathway. The first is the hydrolysis of an alpha-linked peptide bond at
CC       the C-terminal end of the small ubiquitin-like modifier (SUMO)
CC       propeptides, SUMO1, SUMO2 and SUMO3 leading to the mature form of the
CC       proteins. The second is the deconjugation of SUMO1, SUMO2 and SUMO3
CC       from targeted proteins, by cleaving an epsilon-linked peptide bond
CC       between the C-terminal glycine of the mature SUMO and the lysine
CC       epsilon-amino group of the target protein. May down-regulate CTNNB1
CC       levels and thereby modulate the Wnt pathway. Deconjugates SUMO2 from
CC       MTA1. Plays a dynamic role in adipogenesis by desumoylating and
CC       promoting the stabilization of CEBPB (By similarity).
CC       {ECO:0000250|UniProtKB:Q91ZX6, ECO:0000250|UniProtKB:Q9HC62,
CC       ECO:0000269|PubMed:11997515}.
CC   -!- SUBUNIT: Binds to SUMO2 and SUMO3. Interacts with the C-terminal domain
CC       of NUP153 via its N-terminus. Interacts with MTA1 (By similarity).
CC       Binds to axin. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus, nuclear pore complex
CC       {ECO:0000250|UniProtKB:Q9HC62}. Nucleus membrane
CC       {ECO:0000250|UniProtKB:Q9HC62}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q9HC62}; Nucleoplasmic side
CC       {ECO:0000250|UniProtKB:Q9HC62}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q9HC62}. Note=Shuttles between cytoplasm and
CC       nucleus. {ECO:0000250|UniProtKB:Q9HC62}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in brain, lung and
CC       testis.
CC   -!- PTM: Polyubiquitinated; which leads to proteasomal degradation.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase C48 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF260129; AAG34653.1; -; mRNA.
DR   RefSeq; NP_076479.1; NM_023989.1.
DR   SMR; Q9EQE1; -.
DR   BioGRID; 249380; 2.
DR   STRING; 10116.ENSRNOP00000002425; -.
DR   MEROPS; C48.007; -.
DR   iPTMnet; Q9EQE1; -.
DR   PhosphoSitePlus; Q9EQE1; -.
DR   PaxDb; Q9EQE1; -.
DR   PRIDE; Q9EQE1; -.
DR   Ensembl; ENSRNOT00000002425; ENSRNOP00000002425; ENSRNOG00000001773.
DR   GeneID; 78973; -.
DR   KEGG; rno:78973; -.
DR   UCSC; RGD:708378; rat.
DR   CTD; 59343; -.
DR   RGD; 708378; Senp2.
DR   eggNOG; KOG0778; Eukaryota.
DR   GeneTree; ENSGT00940000154951; -.
DR   HOGENOM; CLU_024324_4_0_1; -.
DR   InParanoid; Q9EQE1; -.
DR   OMA; CSMRSEK; -.
DR   OrthoDB; 1480705at2759; -.
DR   PhylomeDB; Q9EQE1; -.
DR   TreeFam; TF316289; -.
DR   Reactome; R-RNO-3065679; SUMO is proteolytically processed.
DR   PRO; PR:Q9EQE1; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000001773; Expressed in frontal cortex and 19 other tissues.
DR   ExpressionAtlas; Q9EQE1; baseline and differential.
DR   Genevisible; Q9EQE1; RN.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0016604; C:nuclear body; ISO:RGD.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005643; C:nuclear pore; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0016605; C:PML body; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0070139; F:SUMO-specific endopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0070140; F:SUMO-specific isopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0009950; P:dorsal/ventral axis specification; IDA:RGD.
DR   GO; GO:0045444; P:fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0060711; P:labyrinthine layer development; ISO:RGD.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
DR   GO; GO:0035562; P:negative regulation of chromatin binding; ISO:RGD.
DR   GO; GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; ISO:RGD.
DR   GO; GO:0032091; P:negative regulation of protein binding; IDA:RGD.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; ISO:RGD.
DR   GO; GO:1901797; P:negative regulation of signal transduction by p53 class mediator; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:RGD.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0031648; P:protein destabilization; ISO:RGD.
DR   GO; GO:0016926; P:protein desumoylation; ISS:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0032875; P:regulation of DNA endoreduplication; ISO:RGD.
DR   GO; GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0051246; P:regulation of protein metabolic process; IDA:RGD.
DR   GO; GO:0060712; P:spongiotrophoblast layer development; ISO:RGD.
DR   GO; GO:0060707; P:trophoblast giant cell differentiation; ISO:RGD.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR003653; Peptidase_C48_C.
DR   Pfam; PF02902; Peptidase_C48; 1.
DR   SUPFAM; SSF54001; SSF54001; 1.
DR   PROSITE; PS50600; ULP_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Hydrolase; Membrane; mRNA transport; Nuclear pore complex;
KW   Nucleus; Phosphoprotein; Protease; Protein transport; Reference proteome;
KW   Thiol protease; Translocation; Transport; Ubl conjugation;
KW   Ubl conjugation pathway; Wnt signaling pathway.
FT   CHAIN           1..588
FT                   /note="Sentrin-specific protease 2"
FT                   /id="PRO_0000101720"
FT   REGION          72..381
FT                   /note="Axin-binding"
FT   REGION          394..558
FT                   /note="Protease"
FT   MOTIF           28..31
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOTIF           47..52
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOTIF           316..331
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        477
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        494
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        547
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         32
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HC62"
FT   MOD_RES         332
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HC62"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HC62"
FT   MUTAGEN         547
FT                   /note="C->S: Abolishes protease activity."
FT                   /evidence="ECO:0000269|PubMed:11997515"
SQ   SEQUENCE   588 AA;  67252 MW;  BEC186367D8284C4 CRC64;
     MYRWLTKVLG TILRLCERPA PGARALLKRR RSSSSLFSTA VDTDEIPAKR PRLDCFIHQV
     KNSLYNAASL FGFPFQLTTK PMVSSACNGT RNVAPSGEVF SNSPSCELTT SGSCSSMLKL
     GNKSPNGISD YPKIRVTVAR DQPRRVLPSF GFTLKSEGYN RRPSGRRHSK SNPESSLPWK
     PQEQGVTEMI SEEGGKGARR PHCTVEEGVQ KDEREKYLKL LERLKEGAHG STFPPAVSHH
     SSQRTQMDTL KTKGWMEEQN HGVRTTHLVP KQYRVVETRG PLCSVRSEKR YSKGKADTEK
     VVGLRFEKDG TRGHQLEPDL SEEVSARLRL GSGSNGLLRR KISVLEAKEK NFPSKEKDRR
     TEDLFELTED MEKEISNALG HGPPDEILSS AFKLRITRGD IQTLKNYHWL NDEVINFYMN
     LLVERSKKQG YPALHALSTF FYPKLKSGGY QAVKRWTKGV NLFDQELVLV PIHRKVHWSL
     VVMDLRKKCL KYLDSMGQKG HRICEILLQY LQDESKTKRN TDLNLLEWTH YSMKPHEIPQ
     QLNGSDCGMF TCKYADYISR DKPITFTQHQ MPLFRKKMVW EILHQQLL
//
